Patent ID: 7498130
Filing Date: 2009-03-03
Classification: A61K

Abstract:
1. A method of reducing viral load in a subject comprising: (a) adding to a blood product comprising ATIII a saccharide able to activate ATIII in an amount sufficient to activate said ATIII; (b) incubating the resulting mixture of the blood product and saccharide under conditions sufficient to activate said ATIII; and (c) administering said mixture and an anti-viral drug into said subject; wherein said saccharide is low molecular weight heparin; said low molecular weight heparin is added in a 0.1-1.0 equimolar amount of the quantity of said ATIII in said blood product; and said subject has one or more viral infections selected from the group consisting of Hepatitis C Virus (HCV) infection and Human Immunodeficiency Virus (HIV) infection.